LAGUNA HILLS, Calif., Feb. 12, 2025 /PRNewswire/ — Prelude Corporation (PreludeDx®), a leader in precision diagnostics for early-stage breast cancer, today announced a partnership with Hannah Storm, ...
A newly released study is challenging the way doctors commonly treat patients with ductal carcinoma in situ (DCIS), known as stage zero breast cancer. DCIS cancer cells are confined inside a milk duct ...
LAGUNA HILLS, Calif., May 30, 2024 /PRNewswire/ -- Prelude Corporation (PreludeDx ®), a leader in precision diagnostics for early-stage breast cancer, today announced that it will share data ...
Improving patient understanding of GEP test results (IMPARTER4): An RCT. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does not include a full text component.
Delaying radiation therapy too long after surgery significantly increases the risk of recurrent tumors in women treated for very early, or what is referred to as "stage 0," breast cancer, according to ...
Adjuvant tamoxifen may reduce recurrence risk for patients with ‘good-risk’ DCIS who forgo radiation
SAN ANTONIO – For patients with “good-risk” ductal carcinoma in situ (DCIS) who underwent breast- conserving surgery and did not receive radiotherapy, tamoxifen significantly decreased the risk of ...
Danielle Fishel is sharing an update about her health. The “Boy Meets World” star said on Monday’s episode of her “Pod Meets World” podcast that she has completed “active cancer treatment” following ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results